DEXCOM, INC. financials

  1. Home
  2. Financials
  3. DXCM
DXCM CIK 0001093557

Source: EDGAR filings · Built 2026-06-02T02:52:07Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 1.07B 617.70M 507.20M 289.20M 43.40M 268.10M
EBITDA 1.16B 817.70M 783.70M 547.10M 367.80M 366.60M
Working Capital 1.89B 1.37B 2.87B 1.83B 2.96B 2.81B
Net Debt 478.70M 1.99B 2.03B 1.51B 1.11B 1.40B
Gross Margin 60.10% 60.46% 63.19% 64.72% 68.63% 66.44%
Operating Margin 19.56% 14.88% 16.50% 13.44% 10.86% 15.54%
Net Margin 17.94% 14.29% 14.95% 11.73% 8.86% 28.53%
Return on Equity (ROE) 30.46% 27.40% 26.18% 16.01% 10.62% 35.42%
Return on Assets (ROA) 13.19% 8.89% 8.64% 6.33% 4.40% 12.81%
Current Ratio 1.88× 1.47× 2.84× 1.99× 5.11× 5.58×
Debt-to-Equity 0.51× 1.23× 1.26× 1.01× 1.06× 1.43×
Effective Tax Rate 23.16% 18.73% 23.78% 12.69% 15.54% -84.53%
Cash Conversion Ratio 1.72× 1.72× 1.38× 1.96× 2.04× 0.87×
Accruals Ratio -0.10× -0.06× -0.03× -0.06× -0.05× 0.02×
SBC % of Revenue 3.42% 4.23% 4.16% 4.35% 4.63% 6.20%
CapEx Coverage 3.89× 2.66× 3.10× 1.76× 1.11× 2.29×
Free Cash Flow Per Share $2.64 $1.50 $1.19 $0.68 $0.10 $0.64

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 31.76× 54.77× 95.45× 138.10× 253.28× 69.50×
P/FCF 25.14× 51.96× 104.10× 167.39× 1326.46× 144.94×
FCF Yield 3.98% 1.92% 0.96% 0.60% 0.08% 0.69%
EV / EBITDA 22.36× 39.59× 63.62× 82.71× 569.45× 100.73×
P/S 5.48× 7.53× 13.20× 15.03× 85.09× 18.44×
P/B 9.30× 14.45× 23.12× 20.52× 102.02× 22.89×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 4.66B 4.03B 3.62B 2.91B 2.45B 1.93B
Cost of Goods and Services Sold 1.86B 1.59B 1.33B 1.03B 768.00M 646.60M
Gross Profit 2.80B 2.44B 2.29B 1.88B 1.68B 1.28B
Research and Development Expense 599.10M 552.40M 505.80M 484.20M 517.10M 359.90M
Selling, General and Administrative Expense 1.29B 1.29B 1.19B 1.01B 810.50M 618.20M
Operating Expenses 1.89B 1.84B 1.69B 1.49B 1.41B 980.60M
Operating Income (Loss) 911.80M 600.00M 597.70M 391.20M 265.80M 299.50M
Income Tax Expense (Benefit) 252.10M 132.80M 168.90M 49.60M 39.90M -251.80M
Net Income (Loss) Attributable to Parent 836.30M 576.20M 541.50M 341.20M 216.90M 549.70M
Earnings Per Share, Basic $2.14 $1.46 $1.40 $0.88 $0.56 $1.46
Weighted Average Number of Shares Outstanding, Basic 390.20M 393.60M 386.00M 389.40M 386.90M 377.50M
Earnings Per Share, Diluted $2.09 $1.42 $1.30 $0.82 $0.53 $1.33
Weighted Average Number of Shares Outstanding, Diluted 405.50M 412.70M 425.50M 427.50M 428.80M 420.40M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 917.70M 606.10M 566.30M 642.30M 1.05B 817.60M
Assets, Current 4.03B 4.30B 4.43B 3.67B 3.68B 3.42B
Assets 6.34B 6.48B 6.26B 5.39B 4.93B 4.29B
Liabilities, Current 2.14B 2.93B 1.56B 1.84B 720.80M 614.10M
Liabilities 3.59B 4.38B 4.20B 3.26B 2.89B 2.46B
Stockholders' Equity Attributable to Parent 2.75B 2.10B 2.07B 2.13B 2.04B 1.55B
Common Stock, Shares, Outstanding 384.80M 390.70M 385.40M 386.30M 388.00M 96.10M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 1.44B 989.50M 748.50M 669.50M 442.50M 475.60M
Payments to Acquire Property, Plant, and Equipment 363.50M 358.80M 236.60M 364.80M 389.20M 199.00M
Net Cash Provided by (Used in) Investing Activities 536.00M -207.50M -507.20M -521.50M -216.10M -1.02B
Payments for Repurchase of Common Stock 500.00M 750.00M 688.70M 557.70M 0 0
Net Cash Provided by (Used in) Financing Activities -1.69B -734.80M -318.60M -552.50M 10.40M 912.10M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (DXCM CIK 0001093557), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

LUMN

Lumen Technologies, Inc.

TFIN

TRIUMPH FINANCIAL, INC.

CNOB

ConnectOne Bancorp, Inc.